Taysha Gene Therapies, Inc. TSHA Non Cash Change In Fair Value Of Term Loan
Non Cash Change In Fair Value Of Term Loan at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept tsha:NonCashChangeInFairValueOfTermLoan.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s non cash change in fair value of term loan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s non cash change in fair value of term loan?
- Taysha Gene Therapies, Inc. (TSHA) reported non cash change in fair value of term loan of $32K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s non cash change in fair value of term loan changed year-over-year?
- Taysha Gene Therapies, Inc.'s non cash change in fair value of term loan decreased by 87.5% year-over-year, from $256K to $32K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s non cash change in fair value of term loan?
- Over 2 years (2023 to 2025), Taysha Gene Therapies, Inc.'s non cash change in fair value of term loan has grown at a -19.3% compound annual growth rate (CAGR), from $1.28M to $832K.
- What does non cash change in fair value of term loan mean?
- This represents the non-cash adjustment to the carrying value of debt obligations measured under the fair value option. It captures changes in the market's assessment of the company's credit risk or interest rate environment. This adjustment is necessary to reconcile net income with cash flow from operations.